My Quote Request
6505-01-078-0669
20 Products
NDC00083-0139-30
HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE CAPSULES
NSN, MFG P/N
6505010780669
NSN
6505-01-078-0669
NDC00083-0139-30
HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE CAPSULES
NSN, MFG P/N
6505010780669
NSN
6505-01-078-0669
MFG
CIBA-GEIGY CORP CIBA PHARMACEUTICALS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS HYDRALAZINE HYDROCHLORIDE ACTIVE INGREDIENT AND 25.000 MILLIGRAMS HYDROCHLOROTHIAZIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC50111-0468-01
PROPRANOLOL HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505010780695
NSN
6505-01-078-0695
NDC50111-0468-01
PROPRANOLOL HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505010780695
NSN
6505-01-078-0695
MFG
PLIVA INC .
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS PROPRANOLOL HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PROPRANOLOL HYDROCHLORIDE TABLETS USP 20MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
LOPRESSOR
METOPROLOL TARTRATE TABLETS,USP
NSN, MFG P/N
6505010782514
NSN
6505-01-078-2514
LOPRESSOR
METOPROLOL TARTRATE TABLETS,USP
NSN, MFG P/N
6505010782514
NSN
6505-01-078-2514
MFG
CIBA-GEIGY CORP GEIGY PHARMACEUTICALS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS METOPROLOL TARTRATE ACTIVE INGREDIENT
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METOPROLOL TARTRATE TABLETS USP 50MG I.S. 100S PG
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 TABLETS
Related Searches:
NDC00028-0051-61
METOPROLOL TARTRATE TABLETS,USP
NSN, MFG P/N
6505010782514
NSN
6505-01-078-2514
NDC00028-0051-61
METOPROLOL TARTRATE TABLETS,USP
NSN, MFG P/N
6505010782514
NSN
6505-01-078-2514
MFG
CIBA-GEIGY CORP GEIGY PHARMACEUTICALS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS METOPROLOL TARTRATE ACTIVE INGREDIENT
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METOPROLOL TARTRATE TABLETS USP 50MG I.S. 100S PG
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 TABLETS
Related Searches:
NDC00904-7772-61
METOPROLOL TARTRATE TABLETS,USP
NSN, MFG P/N
6505010782514
NSN
6505-01-078-2514
NDC00904-7772-61
METOPROLOL TARTRATE TABLETS,USP
NSN, MFG P/N
6505010782514
NSN
6505-01-078-2514
MFG
MAJOR PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS METOPROLOL TARTRATE ACTIVE INGREDIENT
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METOPROLOL TARTRATE TABLETS USP 50MG I.S. 100S PG
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 TABLETS
Related Searches:
NDC51079-0801-20
METOPROLOL TARTRATE TABLETS,USP
NSN, MFG P/N
6505010782514
NSN
6505-01-078-2514
NDC51079-0801-20
METOPROLOL TARTRATE TABLETS,USP
NSN, MFG P/N
6505010782514
NSN
6505-01-078-2514
MFG
UDL LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS METOPROLOL TARTRATE ACTIVE INGREDIENT
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METOPROLOL TARTRATE TABLETS USP 50MG I.S. 100S PG
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 TABLETS
Related Searches:
NDC00005-3246-57
DOCUSATE SODIUM CAPSULES,USP
NSN, MFG P/N
6505010782546
NSN
6505-01-078-2546
NDC00005-3246-57
DOCUSATE SODIUM CAPSULES,USP
NSN, MFG P/N
6505010782546
NSN
6505-01-078-2546
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS DOCUSATE SODIUM ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00054-2198-25
DOCUSATE SODIUM CAPSULES,USP
NSN, MFG P/N
6505010782546
NSN
6505-01-078-2546
NDC00054-2198-25
DOCUSATE SODIUM CAPSULES,USP
NSN, MFG P/N
6505010782546
NSN
6505-01-078-2546
MFG
BOEHRINGER INGELHEIM ROXANE INC. DIV SUB OF BOEHRINGER INGELHEIM CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS DOCUSATE SODIUM ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00085-0254-06
TOLNAFTATE POWDER,USP
NSN, MFG P/N
6505010784622
NSN
6505-01-078-4622
NDC00085-0254-06
TOLNAFTATE POWDER,USP
NSN, MFG P/N
6505010784622
NSN
6505-01-078-4622
MFG
SCHERING CORP AN AFFIL OF SCHERING-PLOUGH CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 PERCENTAGE, W/W TOLNAFTATE ACTIVE INGREDIENT
ADMINISTRATION: TOPICAL
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 GRAMS
PRIMARY CONTAINER TYPE: CAN, AEROSOL
SPECIAL FEATURES: IN A VEHICLE OF BUTYLATED HYDROXYTOLUENE,TALC,AND POLYETHYLENE-POLYPROPYLENE GLYCOL MONOBUTYL ETHER WITH INERT PROPELLANTS
Related Searches:
TINACTIN
TOLNAFTATE POWDER,USP
NSN, MFG P/N
6505010784622
NSN
6505-01-078-4622
MFG
SCHERING CORP AN AFFIL OF SCHERING-PLOUGH CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 PERCENTAGE, W/W TOLNAFTATE ACTIVE INGREDIENT
ADMINISTRATION: TOPICAL
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 GRAMS
PRIMARY CONTAINER TYPE: CAN, AEROSOL
SPECIAL FEATURES: IN A VEHICLE OF BUTYLATED HYDROXYTOLUENE,TALC,AND POLYETHYLENE-POLYPROPYLENE GLYCOL MONOBUTYL ETHER WITH INERT PROPELLANTS
Related Searches:
KLORVESS EFFERVESCENT GRANULES
POTASSIUM BICARBONATE AND POTASSIUM CHLORIDE FOR EFFERVESCENT ORAL SOLUTION,USP
NSN, MFG P/N
6505010785245
NSN
6505-01-078-5245
KLORVESS EFFERVESCENT GRANULES
POTASSIUM BICARBONATE AND POTASSIUM CHLORIDE FOR EFFERVESCENT ORAL SOLUTION,USP
NSN, MFG P/N
6505010785245
NSN
6505-01-078-5245
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.913 GRAMS L-LYSINE MONOHYDROCHLORIDE ACTIVE INGREDIENT AND 0.500 GRAMS POTASSIUM BICARBONATE ACTIVE INGREDIENT AND 1.125 GRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POTASSIUM BICARBONATE & POTASSIUM CHL FOR EFFERVESCENT ORAL SOL 30S
PHYSICAL FORM: GRANULE
PRIMARY CONTAINER CONTENT QUANTITY: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: PACKET
SPECIAL FEATURES: EACH PACKET CONTAINS THE EQUIVALENT TO 20 MEQ EACH OF POTASSIUM AND CHLORIDE
TOTAL PRIMARY CONTAINER QUANTITY: 30
Related Searches:
NDC00245-0035-30
POTASSIUM BICARBONATE AND POTASSIUM CHLORIDE FOR EFFERVESCENT ORAL SOLUTION,USP
NSN, MFG P/N
6505010785245
NSN
6505-01-078-5245
NDC00245-0035-30
POTASSIUM BICARBONATE AND POTASSIUM CHLORIDE FOR EFFERVESCENT ORAL SOLUTION,USP
NSN, MFG P/N
6505010785245
NSN
6505-01-078-5245
MFG
UPSHER-SMITH LABORATORIES INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.913 GRAMS L-LYSINE MONOHYDROCHLORIDE ACTIVE INGREDIENT AND 0.500 GRAMS POTASSIUM BICARBONATE ACTIVE INGREDIENT AND 1.125 GRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POTASSIUM BICARBONATE & POTASSIUM CHL FOR EFFERVESCENT ORAL SOL 30S
PHYSICAL FORM: GRANULE
PRIMARY CONTAINER CONTENT QUANTITY: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: PACKET
SPECIAL FEATURES: EACH PACKET CONTAINS THE EQUIVALENT TO 20 MEQ EACH OF POTASSIUM AND CHLORIDE
TOTAL PRIMARY CONTAINER QUANTITY: 30
Related Searches:
NDC0034-1100-84
SENNA CONCENTRATE,STANDARDIZED ORAL POWDER
NSN, MFG P/N
6505010785460
NSN
6505-01-078-5460
NDC0034-1100-84
SENNA CONCENTRATE,STANDARDIZED ORAL POWDER
NSN, MFG P/N
6505010785460
NSN
6505-01-078-5460
MFG
THE FREDERICK PURDUE COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 65.200 MG. SENNA CONCENTRATE PER ML. OF RECONSTITUTED SOLUTION
ADMINISTRATION: ORAL
FLAVOR: COCOA
PHYSICAL FORM: GRANULE
PRIMARY CONTAINER CONTENT QUANTITY: 12.000 OUNCES
PRIMARY CONTAINER TYPE: CANISTER
Related Searches:
SENOKOT
SENNA CONCENTRATE,STANDARDIZED ORAL POWDER
NSN, MFG P/N
6505010785460
NSN
6505-01-078-5460
SENOKOT
SENNA CONCENTRATE,STANDARDIZED ORAL POWDER
NSN, MFG P/N
6505010785460
NSN
6505-01-078-5460
MFG
THE FREDERICK PURDUE COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 65.200 MG. SENNA CONCENTRATE PER ML. OF RECONSTITUTED SOLUTION
ADMINISTRATION: ORAL
FLAVOR: COCOA
PHYSICAL FORM: GRANULE
PRIMARY CONTAINER CONTENT QUANTITY: 12.000 OUNCES
PRIMARY CONTAINER TYPE: CANISTER
Related Searches:
NDC00029-6407-21
CARBENICILLIN DISODIUM,USP
NSN, MFG P/N
6505010786110
NSN
6505-01-078-6110
NDC00029-6407-21
CARBENICILLIN DISODIUM,USP
NSN, MFG P/N
6505010786110
NSN
6505-01-078-6110
MFG
KING PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: EQUIVALENT TO 20.000 GRAMS CARBENICILLIN
ADMINISTRATION: INTRAVENOUS
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: POWDER SUFFICIENT TO YIELD 20.000 GRAMS CARBENICILLIN
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 100 ML. SIZE BULK DOSE VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
PYOPEN
CARBENICILLIN DISODIUM,USP
NSN, MFG P/N
6505010786110
NSN
6505-01-078-6110
MFG
KING PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: EQUIVALENT TO 20.000 GRAMS CARBENICILLIN
ADMINISTRATION: INTRAVENOUS
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: POWDER SUFFICIENT TO YIELD 20.000 GRAMS CARBENICILLIN
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 100 ML. SIZE BULK DOSE VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
8065-01
SUCCINYLCHOLINE CHLORIDE INJECTION,USP
NSN, MFG P/N
6505010786112
NSN
6505-01-078-6112
8065-01
SUCCINYLCHOLINE CHLORIDE INJECTION,USP
NSN, MFG P/N
6505010786112
NSN
6505-01-078-6112
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS SUCCINYLCHOLINE CHLORIDE PER MILLILITER
ADMINISTRATION: INTRAVENOUS
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE WITH NEEDLE
SPECIAL FEATURES: NEEDLE SIZE 21 GAGE BY 1-1/2 INCHES
Related Searches:
NDC00074-8065-01
SUCCINYLCHOLINE CHLORIDE INJECTION,USP
NSN, MFG P/N
6505010786112
NSN
6505-01-078-6112
NDC00074-8065-01
SUCCINYLCHOLINE CHLORIDE INJECTION,USP
NSN, MFG P/N
6505010786112
NSN
6505-01-078-6112
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS SUCCINYLCHOLINE CHLORIDE PER MILLILITER
ADMINISTRATION: INTRAVENOUS
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE WITH NEEDLE
SPECIAL FEATURES: NEEDLE SIZE 21 GAGE BY 1-1/2 INCHES
Related Searches:
QUELICIN ABBOJECT
SUCCINYLCHOLINE CHLORIDE INJECTION,USP
NSN, MFG P/N
6505010786112
NSN
6505-01-078-6112
QUELICIN ABBOJECT
SUCCINYLCHOLINE CHLORIDE INJECTION,USP
NSN, MFG P/N
6505010786112
NSN
6505-01-078-6112
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS SUCCINYLCHOLINE CHLORIDE PER MILLILITER
ADMINISTRATION: INTRAVENOUS
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE WITH NEEDLE
SPECIAL FEATURES: NEEDLE SIZE 21 GAGE BY 1-1/2 INCHES
Related Searches:
3132
HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE CAPSULES
NSN, MFG P/N
6505010788138
NSN
6505-01-078-8138
3132
HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE CAPSULES
NSN, MFG P/N
6505010788138
NSN
6505-01-078-8138
MFG
CIBA-GEIGY CORP CIBA PHARMACEUTICALS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS HYDRALAZINE HYDROCHLORIDE ACTIVE INGREDIENT AND 50.000 MILLIGRAMS HYDROCHLOROTHIAZIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE